Cargando…

The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer

OBJECTIVE: The study aims to investigate the prognostic value of the lymphocyte-to-monocyte ratio (LMR) in patients with colorectal cancer (CRC) undergoing curative resection and to compare it to established biomarkers including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Joseph C. Y., Chan, David L., Diakos, Connie I., Engel, Alexander, Pavlakis, Nick, Gill, Anthony, Clarke, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott, Williams, and Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300029/
https://www.ncbi.nlm.nih.gov/pubmed/27070934
http://dx.doi.org/10.1097/SLA.0000000000001743
_version_ 1782506120868265984
author Chan, Joseph C. Y.
Chan, David L.
Diakos, Connie I.
Engel, Alexander
Pavlakis, Nick
Gill, Anthony
Clarke, Stephen J.
author_facet Chan, Joseph C. Y.
Chan, David L.
Diakos, Connie I.
Engel, Alexander
Pavlakis, Nick
Gill, Anthony
Clarke, Stephen J.
author_sort Chan, Joseph C. Y.
collection PubMed
description OBJECTIVE: The study aims to investigate the prognostic value of the lymphocyte-to-monocyte ratio (LMR) in patients with colorectal cancer (CRC) undergoing curative resection and to compare it to established biomarkers including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), modified Glasgow prognostic score (mGPS), and combined BRAF-mismatch repair (MMR) status. BACKGROUND: The prognostic significance of systemic inflammatory markers in CRC such as the NLR, PLR, and mGPS has been well defined. Commonly used genetic markers such as combined BRAF-MMR status have also been found to be prognostic. Recent evidence, although limited, suggests that the preoperative LMR may be prognostic in CRC. METHODS: Data from the Northern Sydney Local Health District from January 1998 to December 2012 were retrospectively collected. Of 3281 consecutive patients identified, 1623 patients who underwent curative resection were deemed eligible for inclusion. The relation between the LMR, clinicopathologic variables, and other biomarkers were analyzed in Kaplan-Meier log-rank survival analysis and then multivariate Cox regression models looking for association with overall survival (OS). RESULTS: In multivariate analysis of all patients, elevated LMR was associated with better OS (hazard ratio 0.569, 95% confidence interval: 0.478–0.677, P < 0.001) independent of age (P < 0.001), T stage (P < 0.001), N stage (P < 0.001), and grade (P = 0.049). The NLR, PLR, and combined BRAF-MMR status were not independently significant. In multivariate subgroup analysis of 389 patients with mGPS, LMR remained the only independently significant biomarker (hazard ratio 0.620, 95% confidence interval: 0.437–0.880, P = 0.007). CONCLUSIONS: The LMR is an independent predictor of OS in patients with CRC undergoing curative resection and appears to be superior to pre-existing biomarkers.
format Online
Article
Text
id pubmed-5300029
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott, Williams, and Wilkins
record_format MEDLINE/PubMed
spelling pubmed-53000292017-02-21 The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer Chan, Joseph C. Y. Chan, David L. Diakos, Connie I. Engel, Alexander Pavlakis, Nick Gill, Anthony Clarke, Stephen J. Ann Surg Original Articles OBJECTIVE: The study aims to investigate the prognostic value of the lymphocyte-to-monocyte ratio (LMR) in patients with colorectal cancer (CRC) undergoing curative resection and to compare it to established biomarkers including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), modified Glasgow prognostic score (mGPS), and combined BRAF-mismatch repair (MMR) status. BACKGROUND: The prognostic significance of systemic inflammatory markers in CRC such as the NLR, PLR, and mGPS has been well defined. Commonly used genetic markers such as combined BRAF-MMR status have also been found to be prognostic. Recent evidence, although limited, suggests that the preoperative LMR may be prognostic in CRC. METHODS: Data from the Northern Sydney Local Health District from January 1998 to December 2012 were retrospectively collected. Of 3281 consecutive patients identified, 1623 patients who underwent curative resection were deemed eligible for inclusion. The relation between the LMR, clinicopathologic variables, and other biomarkers were analyzed in Kaplan-Meier log-rank survival analysis and then multivariate Cox regression models looking for association with overall survival (OS). RESULTS: In multivariate analysis of all patients, elevated LMR was associated with better OS (hazard ratio 0.569, 95% confidence interval: 0.478–0.677, P < 0.001) independent of age (P < 0.001), T stage (P < 0.001), N stage (P < 0.001), and grade (P = 0.049). The NLR, PLR, and combined BRAF-MMR status were not independently significant. In multivariate subgroup analysis of 389 patients with mGPS, LMR remained the only independently significant biomarker (hazard ratio 0.620, 95% confidence interval: 0.437–0.880, P = 0.007). CONCLUSIONS: The LMR is an independent predictor of OS in patients with CRC undergoing curative resection and appears to be superior to pre-existing biomarkers. Lippincott, Williams, and Wilkins 2017-03 2016-04-08 /pmc/articles/PMC5300029/ /pubmed/27070934 http://dx.doi.org/10.1097/SLA.0000000000001743 Text en Copyright © 2016 The Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Original Articles
Chan, Joseph C. Y.
Chan, David L.
Diakos, Connie I.
Engel, Alexander
Pavlakis, Nick
Gill, Anthony
Clarke, Stephen J.
The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
title The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
title_full The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
title_fullStr The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
title_full_unstemmed The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
title_short The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
title_sort lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300029/
https://www.ncbi.nlm.nih.gov/pubmed/27070934
http://dx.doi.org/10.1097/SLA.0000000000001743
work_keys_str_mv AT chanjosephcy thelymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT chandavidl thelymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT diakosconniei thelymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT engelalexander thelymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT pavlakisnick thelymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT gillanthony thelymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT clarkestephenj thelymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT chanjosephcy lymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT chandavidl lymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT diakosconniei lymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT engelalexander lymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT pavlakisnick lymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT gillanthony lymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer
AT clarkestephenj lymphocytetomonocyteratioisasuperiorpredictorofoverallsurvivalincomparisontoestablishedbiomarkersofresectablecolorectalcancer